Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06830590

Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani Population

This study is looking at the biological characteristics of early operable primary breast cancer in Pakistani Population by using IHC

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Breast Cancer Breast Diseases Breast Neoplasms Molecular Pathway Deregulation Neoplasms Neoplasms by Site Skin Diseases Skin and Connective Tissue Diseases Treatment

Sex eligibility

Female

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women with confirmed diagnosis of breast cancer without history of taking neoadjuvant therapy Good quality tumour samples available for IHC

Exclusion criteria

  • patients received pre-operative chemotherapy or radiotherapy

Treatment and study plan

Molecular characterisation

Procedure

All patients treated by surgery were included without any neoadjuvant therapy

Primary outcomes

  1. Breast cancer specific survival in correlation with molecular pattern

    Time frame: 10 years

Study contacts

Contact information is provided by the study sponsor or research team.

Binafsha Manzoor M Syed, MBBS, PhD

CONTACT

[email protected]

+923332749201

Sponsors and collaborators

Lead sponsor

Liaquat University of Medical & Health Sciences

Other

Registry information

Acronym: BrCa

Important dates

Study start
2016
Primary completion
2025
Study completion
2025
First posted
Feb 17, 2025
Registry last updated
Aug 13, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.